key: cord-0941892-y27pf1hy authors: Hiransuthikul, Akarin; Janamnuaysook, Rena; Himma, Linrada; Taya, Chiraporn; Amatsombat, Tidarat; Chumnanwet, Phongdanai; Samitpol, Kritima; Chancham, Artsanee; Kongkapan, Jiratchaya; Rueannak, Jeeranuch; Getwongsa, Pintusorn; Srimanus, Peevara; Teeratakulpisarn, Nipat; Thammajaruk, Narukjaporn; Avery, Matthew; Wansom, Tanyaporn; Mills, Stephen; Ramautarsing, Reshmie A.; Phanuphak, Nittaya title: Acceptability and satisfaction towards self‐collection for chlamydia and gonorrhoea testing among transgender women in Tangerine Clinic, Thailand: shifting towards the new normal date: 2021-09-08 journal: J Int AIDS Soc DOI: 10.1002/jia2.25801 sha: 99981d0a01532c3ae6b8e01f00ce6e8f68ab5cb1 doc_id: 941892 cord_uid: y27pf1hy INTRODUCTION: Provider‐collected swabs are an unappealing procedure for many transgender women and may have led to suboptimal rates of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) testing. Self‐collection for CT/NG testing is recommended for men who have sex with men. However, the information on acceptability and clinical performance to support a recommendation for transgender women is lacking. We aimed to determine the acceptability and satisfaction towards self‐collection for CT/NG testing among Thai transgender women. METHODS: Thai transgender women who attended Tangerine Clinic (a transgender‐led, integrated, gender‐affirming care and sexual health services clinic in Bangkok, Thailand) between May and July 2020 and had condomless sexual intercourse within the past six months were offered to collect urine and perform self‐swabs of pharyngeal, rectal, and if applicable, neovaginal compartments for pooled nucleic acid amplification testing for CT/NG infections. Participants received a diagram, video and oral instructions about how to perform self‐collection procedure. Those who accepted self‐collection were also offered to receive provider collection to evaluate the performance between the two methods. Self‐administered questionnaires were used to assess satisfaction. RESULTS: Among 216 transgender women enrolled, 142 (65.7%) accepted self‐collection. All who accepted had pharyngeal, rectal and urine samples collected. Of 31 transgender women who had undergone genital surgery, 28 (90.3%) accepted neovaginal self‐swab. The acceptance rate increased from 46.2% in May to 84.5% in July 2020. One participant had an invalid result. All transgender women who accepted self‐collection could perform it without assistance, and 82.8% were highly satisfied with the method. None reported dissatisfaction. Due to the COVID‐19 pandemic, provider collection services were discontinued early, and only eight transgender women were able to perform both methods for performance evaluation. The performance agreement was 100%. CONCLUSIONS: Thai transgender women had high acceptability and satisfaction towards self‐collection for CT/NG testing. The performance was promising compared to provider collection. Our results support the implementation of self‐collection to the sexually transmitted infection services, particularly during the COVID‐19 pandemic where physical distancing is the new normal. A larger study is warranted to determine the performance of self‐collection for CT/NG testing in each anatomical compartment and confirm the performance between self‐collection and provider collection. Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections are serious global health issues and disproportionately affect key populations, including transgender women [1, 2] . Globally, the overall prevalence of CT/NG infections among transgender women ranged variedly between regions and studies, and can be as high as 28.6% for CT infection and 21.4% for NG infection [3, 4] ; a substantially higher number compared to the general population (2.7% to 4.2% for CT infection and 0.6% to 0.8% for NG infection) [1, 2] . Data from community-based clinics using provider-collected swabs among sexually active Thai transgender throughout Thailand found that CT and NG infection prevalence was 23.0% and 14.5% women, respectively [5] . High prevalence of CT/NG infections is a concern because of their association with HIV acquisition and transmission [1, 2] . Unfortunately, the lack of routine screening may result in a missed opportunity to diagnose and treat these curable infections, as most CT/NG infections are asymptomatic. Even if screening was made, samplings from an inadequate number of anatomical sites could still lead to missed diagnoses, particularly among transgender women [3, 5] . In a previous study conducted by our group using provider-collected swabs, 46% to 69% of CT/NG infections among transgender women were isolated from a single anatomical site. If urine screening was conducted alone, a 94% of CT/NG cases among transgender women would have been missed [5] . While there are currently no separate guidelines for transgender women, the US Centers for Disease Control and Prevention (CDC) recommends that healthcare providers assess all possible anatomy and patterns of sexual behaviour among transgender women [6] . However, the traditional provider-collected swabs might be unappealing to transgender individuals. Concerns over discrimination and insensitivity in healthcare settings, lack of trained healthcare providers, perceived provider incompetence, gender dysphoria centred around the genitals or cultural inappropriateness of showing their bodies to the other gender can pose barriers to CT/NG screening [7] [8] [9] [10] . To avoid such issues, self-collection, which is a private and simple noninvasive procedure, could be an alternative to provider-collected sampling and provide an opportunity to enhance active case finding. In addition, this may also be beneficial and encouraging for transgender women clients to enter sexually transmitted infection (STI) screening services during the COVID-19 pandemic when physical distancing is recommended. Our primary objective was to determine the acceptability and satisfaction towards self-collection for CT/NG testing among Thai transgender women attending Tangerine Clinic, a transgender-led, integrated, gender-affirming care and sexual health service in Bangkok, Thailand. All transgender women who reported condomless sexual intercourse within the past six months were routinely offered CT/NG testing from all anatomical sites (i.e., pharyngeal swabs, rectal swabs, urine and, if applicable, neovaginal swabs) regardless of their self-reported exposure site(s) using self-collected methods between May and July 2020. Those who accepted self-collection were also offered to receive provider collection to evaluate the performance between the two methods. Self-collection was initially planned as an option for those who do not prefer provider collection starting May 2020. However, provider collection was discontinued early in the same month in response to the growing impact of the COVID-19 pandemic to promote physical distancing. Consequently, those who refused self-collection were unable to test for CT/NG infections using provider collection. Moreover, those who accepted self-collection were no longer offered to receive provider collection for performance evaluation. Selfadministered questionnaires were used to assess participants' demographic data and risk behaviours. An additional questionnaire was used to assess participants' satisfaction towards self-collection among those who accepted self-collection. The staff gave the clients a diagram and a video instruction ( Figure 1 , a video instruction in Thai can be found in Supporting file S1 and at https://www.youtube.com/watch? v=hqg-725AmEA) and also oral instructions about how to perform self-collection. Except for participants who were enrolled in the performance evaluation between self-collection and provider collection, samples were pooled and tested for CT/NG infections using nucleic acid amplification testing (NAAT; Abbott Real Time CT/NG, Abbott Molecular Inc., IL, USA). Participants who tested positive for CT/NG infection received treatment according to the World Health Organization's (WHO) recommendations [11, 12] . Tangerine Clinic data collection and analysis were approved by the Institutional Review Board of the Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand (IRB No. 158/56). All clients provided verbal consent before receiving services at Tangerine Clinic. Demographic data, risk behaviours and responses to self-collection were summarized as median (interquartile range (IQR)) and number (percentage) for continuous and Of a total of 216 transgender women who were offered to perform self-collection, 142 (65.7%) accepted. Besides a modest but significantly older age among transgender women accepted self-collection, and there were no other significant differences in characteristics between those who accepted and refused self-collection ( Table 1 ). The self-collection acceptance rate gradually increased from 46.2% in May to 84.5% in July (Table 2) . Among 142 transgender women who accepted selfcollection, all had samples collected from pharyngeal swabs, rectal swabs and urine; and 28 out of 31 (90.3%) transgender women who underwent genital surgery had an additional sample collected from neovaginal swabs. Results from selfcollection of all but one transgender woman (99.3%) were valid; the only one invalid result was due to faecal contamination from rectal swabs. The prevalence of CT and NG infections among transgender women performing self-collection was 22.5% (32/142) and 17.6% (25/142), respectively. All transgender women who accepted self-collection could perform it without assistance, and 82.8% were highly satisfied with the method (Table 3) . None reported dissatisfaction. Overall, 69.5% found self-collection to be simple, and 65.6% expressed no concern with this sample collection method. The most common concern over self-collection was that improper technique might lead to incorrect results (33.6%). Up to 97% would choose to do self-collection again in the future, and all would recommend this method to their peers. Using multivariable logistic regression, we found no characteristic that was significantly associated with accepting self-collection (Supporting file S2). Due to the COVID-19 pandemic during the study period, provider collection services were discontinued early, and only eight transgender women were able to do both self-collection and provider collection for performance evaluation. The performance agreement was 100%. All had samples collected from pharyngeal swabs, rectal swabs and urine; and six transgender women had an additional sample from neovaginal swabs. The performance agreement between self-collection and provider collection was 100%. We demonstrated high acceptability of self-collection for CT/NG infections among Thai transgender women, with an 89% increase in acceptance rate during the three-month period of launching the service. Transgender women also showed high satisfaction towards self-collection, and only onethird expressed any concern about the method, mainly regarding the correct technique of performing self-collection. Increased uptake of CT/NG testing is among the first step to strengthen the continuum of STI prevention, diagnosis, treatment and care [13] . However, an STI testing rate of as low as 18% was demonstrated among sexually active transgender women in the United States despite having high-risk behaviours [14] . Multiple factors such as underlying anxiety or feeling of uneasiness towards providers and past experiences of discrimination in healthcare settings might lead to low testing uptake [15] [16] [17] . Self-collection can eliminate an unfavourable aspect of the encounter with a healthcare provider. Our findings of high acceptability were consistent with a previous study among young US transgender women [18] . The acceptance rate nearly doubled throughout the study period (from 43.9% in May to 82.8% in July). While the dramatic increase in acceptance rate may be due to word-ofmouth and suggestions between transgender peers in the community, we hypothesized that the biggest factor was the COVID-19 pandemic. Because we implemented self-collection into our services during the early stage of the COVID-19 pandemic in our country, the increase in acceptance rate might be in part due to growing emphasis on physical distancing and the lack of provider-collected services in our facility, which was discontinued due to the growing concern over COVID-19 pandemic. Based mainly on MSM studies, the CDC recommended that NAAT from self-collected swabs is a reasonable alternative to provider-collected rectal swabs for CT/NG testing [19] . However, there are currently no U.S. Food and Drug Administration (FDA)-approved testing methods specifically for transgender women as well as for neovaginal specimens. Although our purpose of performance evaluation was discontinued early due to the COVID-19 pandemic, the results were promising among eight participants. Considering that self-collection was highly acceptable and satisfied the transgender women and showed promising performance compared to the traditional provider collection, we recommend implementing selfcollection to the STI services, particularly during the COVID-19 pandemic where physical distancing is the new normal. Certain limitations need to be considered. Participants who refused to perform self-collection were unable to receive provider collection due to the COVID-19 pandemic. Therefore, we could not compare the prevalence of CT/NG infections between the two methods. Moreover, we did not explore the reasons for the refusal. The questionnaire used to assess acceptability and satisfaction towards self-collection did not specifically explore each anatomical site but rather the overall experience. There were substantial missing demographic data among our participants, which might lead to missing associated factors with self-sampling acceptance. Although the performance of self-collection was promising, we cannot conclude with great confidence due to the early discontinuation of participants enrolled in the performance evaluation between the two methods. Lastly, all self-collection instructions in our study were in Thai. This may limit the generalizability to apply our instructions to other regions. We were able to translate the diagram for the readers. However, we made a new version of the video instruction in English after the study period to aid other regions in advocating self-collection services for transgender women (Supporting file S3 and at https://www. youtube.com/watch?v=U6oYaDuhVmQ). We demonstrated high acceptability and satisfaction towards self-collection for CT/NG testing among Thai transgender women. The performance was promising compared to provider collection. Our results should pave the way for integrating self-collection to the STI services, particularly during the COVID-19 pandemic where physical distancing is the new normal. A larger study is warranted to determine the performance of self-collection for CT/NG testing in each anatomical compartment and confirm the performance between selfcollection and provider collection. The authors declare that they have no competing interests. A.H. interpreted the data and drafted the manuscript. A.H. and C.T. performed statistical analysis. R.J. and L.H. coordinated the study and oversaw data management. T.A., P.C., K.S., A.C., J.K., J.R., P.G. and P.S. recruited, enrolled, collected data and provided technical inputs for participants. N.Te. oversaw participants. N.Th. performed laboratory testing. M.A. and S.M. approved the study initiation. R.R. and N.P. participated in study design. N.P. initiated the concept for the study. All authors critically reviewed and approved the final draft of manuscript. Additional information may be found under the Supporting Information tab for this article: SUPPORTING INFORMATION SUPPORTING INFORMATION WHO Guidelines for the Treatment of Chlamydia trachomatis. Geneva: World Health Organization WHO Guidelines for the Treatment of Neisseria gonorrhoeae. Geneva: World Health Organization Sexually transmitted infection screening, prevalence and incidence among South African men and transgender women who have sex with men enrolled in a combination HIV prevention cohort study: the Sibanye Methods for Prevention Packages Programme (MP3) project Prevalence of sexually transmitted infections and human immunodeficiency virus in transgender persons: a systematic review High burden of chlamydia and gonorrhoea in pharyngeal, rectal and urethral sites among Thai transgender women: implications for anatomical site selection for the screening of STI Sexually transmitted diseases treatment guidelines Test performance and acceptability of self-versus providercollected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients A systematic review of social stress and mental health among transgender and gender non-conforming people in the United States Transgender stigma and health: a critical review of stigma determinants, mechanisms, and interventions Acceptability of testing for anorectal sexually transmitted infections and self-collected anal swabs in female sex workers, men who have sex with men and transgender women in Papua New Guinea WHO Guidelines for the Treatment of Neisseria gonorrhoeae. Geneva: World Health Organization WHO Guidelines for the Treatment of Chlamydia trachomatis. Geneva: World Health Organization Variations in testing for HIV and other sexually transmitted infections across gender identity among transgender youth Opportunities and gaps in primary care preventative health services for transgender patients: a systemic review Transgender women, hormonal therapy and HIV treatment: a comprehensive review of the literature and recommendations for best practices Sexual risk behaviors and psychosocial health concerns of female-to-male transgender men screening for STDs at an urban community health center Prevalence and perceived acceptability of nongenital sexually transmitted infection testing in a cohort of young transgender women Center for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines We thank all participants for their participation in the study and for their trust in us. We are grateful for the staff from Tangerine Clinic for their tireless effort in taking care of our participants. This work was supported by LINKAGES Project (AID-OAA-A-14-00045), which is led by FHI 360. This work was made possible by the United States Agency for International Development (USAID) and the United States President's Emergency Plan for AIDS Relief (PEPFAR) through the Linkages across the Continuum of HIV Services for Key Populations Affected by HIV (LINKAGES) project. The content does not necessarily reflect the views of USAID, PEPFAR or the US Government.